Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1.

Saved in:
Bibliographic Details
Title: Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1.
Authors: Riddler SA; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Para M; Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA., Benson CA; Department of Medicine, University of California San Diego, San Diego, California, USA., Mills A; SoCal Men's Medical Group, Los Angeles, California, USA., Ramgopal M; Midway Specialty Care Center, Fort Pierce, Florida, USA., DeJesus E; Orlando Immunology Center, Orlando, Florida, USA., Brinson C; Central Texas Clinical Research, Austin, Texas, USA., Cyktor J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Jacobs J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Koontz D; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mellors JW; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Laird GM; Accelevir Diagnostics, Baltimore, Maryland, USA., Wrin T; Monogram Biosciences, South San Francisco, California, USA., Patel H; Gilead Sciences Inc., Foster City, California, USA., Guo S; Gilead Sciences Inc., Foster City, California, USA., Wallin J; Gilead Sciences Inc., Foster City, California, USA., Boice J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Zhang L; Gilead Sciences Inc., Foster City, California, USA., Humeniuk R; Gilead Sciences Inc., Foster City, California, USA., Begley R; Gilead Sciences Inc., Foster City, California, USA., German P; Gilead Sciences Inc., Foster City, California, USA., Graham H; Gilead Sciences Inc., Foster City, California, USA., Geleziunas R; Gilead Sciences Inc., Foster City, California, USA., Brainard DM; Gilead Sciences Inc., Foster City, California, USA., SenGupta D; Gilead Sciences Inc., Foster City, California, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jun 01; Vol. 72 (11), pp. e815-e824.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciaa1534